Daiichinkyo Co (TSE:4568) Change In Receivables : 円-69,893 Mil (TTM As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Daiichinkyo Co Change In Receivables?

Daiichinkyo Co's change in receivables for the quarter that ended in Mar. 2024 was 円19,865 Mil. It means Daiichinkyo Co's Accounts Receivable declined by 円19,865 Mil from Dec. 2023 to Mar. 2024 .

Daiichinkyo Co's change in receivables for the fiscal year that ended in Mar. 2024 was 円-69,893 Mil. It means Daiichinkyo Co's Accounts Receivable increased by 円69,893 Mil from Mar. 2023 to Mar. 2024 .

Daiichinkyo Co's Accounts Receivable for the quarter that ended in Mar. 2024 was 円454,188 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Daiichinkyo Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 96.74.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Daiichinkyo Co's liquidation value for the three months ended in Mar. 2024 was 円11,385 Mil.

Daiichinkyo Co Change In Receivables Historical Data

The historical data trend for Daiichinkyo Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daiichinkyo Co Change In Receivables Chart

Daiichinkyo Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

110,165.00

83,093.00

-19,060.00

-64,584.00

-69,893.00

Daiichinkyo Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															8,836.00	-18,628.00	-15,993.00	-55,137.00	19,865.00

Daiichinkyo Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-69,893 Mil.

Daiichinkyo Co (TSE:4568) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Daiichinkyo Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	454188	/	428419	*	91
=	96.74

2. In Ben Graham's calculation of liquidation value, Daiichinkyo Co's accounts receivable are only considered to be worth 75% of book value:

Daiichinkyo Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1224220	-	1772532	+	0.75 * 454188	+	0.5 * 438111
=	11,385

Daiichinkyo Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Daiichinkyo Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Daiichinkyo Co (TSE:4568) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daiichi Sankyo Co Ltd (TSE:4568) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

DSNKY:USA DSKYF:USA D4S:Germany

Address

3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, JPN, 103-8426

Website

https://www.daiichisankyo.com

Daiichi Sankyo was established by the merger of Daiichi Pharmaceuticals and Sankyo in 2005. As of 2021, approximately half of revenue comes from its Japan businesses, which will shrink in the future as the company expands its global footprint. Its primary growth driver is its leading platform of antibody drug conjugates. Its three lead ADCs are Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu entered the clinic in 2015 and received its first U.S approval in December 2019 for third-line late-stage HER2-positive breast cancer. It is also approved for HER2-positive stomach cancers and HER2 mutant non-small cell lung cancer.

Daiichinkyo Co (TSE:4568) Headlines

No Headlines